Optimizing influenza vaccine allocation by age using cost-effectiveness analysis : a comparison of 6720 vaccination program scenarios in children and adults in Belgium
Source
Epidemics - ISSN 1755-4365-51 (2025) p. 1-9
Influential drivers of the cost-effectiveness of respiratory syncytial virus vaccination in European older adults : a multi-country analysis
Source
BMC medicine - ISSN 1741-7015-23:1 (2025) p. 1-17
Pricey or priceless : cost-effectiveness of respiratory syncytial virus (RSV) prevention in infants
Source
The Lancet regional health. Americas - ISSN 2667-193X-29 (2024) p. 1-2
The age profile of respiratory syncytial virus burden in preschool children of low- and middle-income countries : a semi-parametric, meta-regression approach
Source
PLoS medicine - ISSN 1549-1277-20:7 (2023) p. 1-25
Economic burden and health-related quality-of-life among infants with respiratory syncytial virus infection : a multi-country prospective cohort study in Europe
Source
Vaccine - ISSN 0264-410X-41:16 (2023) p. 2707-2715